MFDS — authorised 23 December 1999
- Marketing authorisation holder: INO
- Status: likely_approved
🇰🇷 Inomax in South Korea
MFDS authorised Inomax on 23 December 1999
Marketing authorisation
Inomax in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in South Korea
Frequently asked questions
Is Inomax approved in South Korea?
Yes. MFDS authorised it on 23 December 1999.
Who is the marketing authorisation holder for Inomax in South Korea?
INO holds the South Korean marketing authorisation.